We therefore combined methylation data from patient tumor tissues and cell lines following decitabine treatment to converge on six genes (CRIP1, G0S2, MLH1, OPN3, S100 and TUBB2A) as the classifier. This evidence concerns the gene CRIP1 and neoplasm.